Nutex Health Inc.

What they do

Nutex Health operates three segments: hospital division (26-27 micro-hospitals, specialty hospitals, and hospital outpatient departments), population health management (IPAs and MSO services), and real estate (ownership and leasing of hospital facilities). The hospital division generates revenue from emergency and inpatient services, primarily as an out-of-network provider, while the PHM division manages provider networks and risk-bearing contracts.

Revenue drivers

• Hospital Division — Generates net patient service revenue from emergency and inpatient care at micro-hospitals and HOPDs; >99% of revenue comes from insurers and other third parties, with ~1% from Medicare/Medicaid and self-pay.
• Population Health Management (PHM) Division — Owns and operates IPAs and a management services organization, providing management and administrative services to affiliated hospitals and physician groups; revenue from management fees and risk-bearing contracts.
• Real Estate Division — Owns and leases land and buildings to hospital entities, including the corporate headquarters; contributes rental income and supports facility development.

Recent performance

For Q2 2026, revenue was $210.8 million, down 13.6% from $244.0 million in Q2 2025, while net income attributable to Nutex Health was $65.8 million (diluted EPS $9.38) versus a loss of $17.7 million in the prior year. Six-month revenue was $427.2 million, down 6.3%, but net income soared to $112.6 million (diluted EPS $15.87). Total hospital visits increased 9.6% in Q2 and 6.2% in the six months year-over-year. Operating cash flow was $34.2 million in Q2 and $109.7 million in the six months, with long-term debt of $31.1 million.

Strategy

Management is focused on growing the hospital network, with 26 facilities at year-end 2025 and nine de novo micro-hospitals in development; as of June 30, 2026, the count was 27. The company plans to contract directly with more commercial payors to align reimbursement with value. It is also optimizing the independent dispute resolution (IDR) process, having renegotiated its HaloMD agreement to a pay-on-collected basis and benefiting from a reduced CMS administrative fee. Additionally, Nutex retains flexibility to perform dispute resolution services in-house or via another vendor for future facilities.

Risks

• No Surprises Act and IDR uncertainty — Regulatory and litigation uncertainty under the No Surprises Act could reduce cash collections and increase dispute costs, and HaloMD has been subject to lawsuits by insurers.
• Out-of-network reimbursement dependency — The hospital division operates largely as an out-of-network provider without negotiated rates, creating exposure to payer disputes and collection variability.
• Revenue volatility from IDR timing — Revenue decreased in 2026 partly due to favorable IDR outcomes realized in early 2025, highlighting variability in timing and amounts of dispute resolutions.
• Related-party and VIE consolidation risks — Physician LLCs and Real Estate VIEs, often controlled by related parties, are consolidated; changes in these relationships could affect financials and operations.

Outlook

Management expects the favorable IDR changes (HaloMD amendment and reduced CMS fee) to reduce normalized contract services expenses by approximately 25-30% prospectively. The company anticipates continued growth in hospital visits and operational efficiencies. However, management cautions that actual contract services expenses may differ significantly based on regulatory and operational factors.